A potential breakthrough in the ongoing AIDS crisis could be deprioritized due to the decisions of noted vaccine skeptic Robert F. Kennedy, Jr. In his capacity as the Secretary of Health and Human ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

The mRNA Therapeutics market is expanding due to advancements in drug development, personalized medicine, and delivery technologies. Opportunities arise from the technology's success in vaccines and ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

Robert F. Kennedy Jr. has announced that his department will end funding for a series of mRNA-based vaccines aimed at ...